DLA Piper represented Liquidia, while Latham & Watkins represented the underwriters in the offering.Liquidia Corporation, a biopharmaceutical company focused on the development and commercialization of products…
Standard 1 Year Membership Required
You must be a Standard 1 Year member to access this content.
Already a member? Log in here
